Continuous subcutaneous deferoxamine therapy improved liver function and reduced iron overload in patients with beta-thalassaemia. This treatment led to significant decreases in liver density and ferritin levels, alongside improved liver enzyme activities.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science: